Skip to main content
Article thumbnail
Location of Repository

Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia

By Catalin Mindrescu, Rakesh P Gupta, Eileen V Hermance, Mary C DeVoe, Vikas R Soma, John T Coppola and Cezar S Staniloae
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. 2006.Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease.
    2. (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.
    3. (1993). Benefi cial effect of cholesterollowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.
    4. (2000). Benefi cial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot Essent Fatty Acids,
    5. (1995). Benefi cial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.
    6. (1999). Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    7. (2006). Coronary artery disease in South Asians: an emerging risk group. Cardiol Rev,
    8. (2003). Detection of endothelial dysfunction with brachial artery ultrasound scanning.
    9. (1993). Dietary fi sh oil augments nitric oxide production or release in patients with type 2 (noninsulin-dependent) diabetes mellitus.
    10. (1997). Dietary supplementation with marine fi sh oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study.
    11. (2000). Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men.
    12. (2002). Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects.
    13. (2004). Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study.
    14. (2005). Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH). Curr Med Res Opin,
    15. (1998). Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    16. (1999). Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. Diabetes Care,
    17. (2003). Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol,
    18. (2001). Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot Essent Fatty Acids,
    19. (1988). Fish oil and ischaemic heart disease in Greenland.
    20. (2002). Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation.
    21. (2001). Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin. Cardiovasc Res,
    22. (2002). Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol,
    23. (2004). INTERHEART Study Investigators. Effect of potentially modifi able risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
    24. (2002). International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent fl ow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.
    25. (1999). Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico.
    26. (1999). Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease.
    27. (2008). Methodological approaches to optimize reproducibility and power in clinical studies of fl ow-mediated dilation.
    28. (2004). n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond),
    29. (1995). Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.
    30. Physiology of the endothelium.
    31. (2005). Pleiotropic effects of statins. Ann Rev Pharmacol Toxicol,
    32. (2006). Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet.
    33. (1999). Regulation of endotheliumderived nitric oxide production by the protein kinase Akt.
    34. (1990). Regulatory functions of the vascular endothelium.
    35. (2006). South Asians and cardiovascular risk: what clinicians should know. Circulation,
    36. (2001). Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
    37. (1998). Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
    38. (1994). Vasorelaxant properties of n-3 polyunsaturated fatty acids in aortas from spontaneously hypertensive and normotensive rats.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.